This technology is a biomaterial-based drug delivery patch with a multi-layered structure, comprising an inner core layer and an outer layer made of ECM-based hybrid ink.
There was a need for a delivery material capable of precisely controlling the drug release sequence and rate.
This technology controls the drug release sequence and rate using a multi-layered ECM hybrid ink structure with varying crosslinking densities and growth factors.
WO2023-132407A1